🇺🇸 FDA
Pipeline program

Rebamipide 2% ophthalmic solution

RVK-25-I01

Approved small_molecule active

Quick answer

Rebamipide 2% ophthalmic solution for Dry Eye Disease (DED) is a Approved program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Samsung Bioepis NL B.V.
Indication
Dry Eye Disease (DED)
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials